🖼
Figure 1 — Targeting the D Series Resolvin Receptor System for the Treatment of Osteoarthri
active
paper figure
Created: 2026-04-21T18:29:40
By: paper_figures_tool
Quality:
50%
🔗 External
ID: paper-fig-paper-796580b4c70c-1
Figure 1Figure 1
Expression of resolvin receptors ALX and ChemR23 in human osteoarthritis (OA) joint tissue. A and B, Transformed C t values for resolvin receptors ALX and ChemR23 mRNA in synovium ( A ) and medial tibial plateau ( B ) specimens obtained from patients with end‐stage OA. Expression of ChemR23 was significantly higher than that of ALX in both OA synovium (n = 15 specimens) ( A ) and medial tibial plateau (n = 14 specimens) ( B ), as shown by a larger transformed C t value (maximum cycle number for run – cycle number at which exponential amplification occurs). Bars show the mean ± SEM. ∗∗∗∗ = P < 0.0001 by unpaired t ‐test. C–F, Correlations of ALX and ChemR23 with the cytokine interleukin‐6 (IL‐6) and the enzyme 15‐lipoxygenase 1 (15‐LOX‐1) in human medial tibial plateau tissue. G–J, Correlations of ALX and ChemR23 with IL‐6 and 15‐LOX‐1 in human synovium.
▸Metadata
| pmid | paper-796580b4c70c |
| caption | Expression of resolvin receptors ALX and ChemR23 in human osteoarthritis (OA) joint tissue. A and B, Transformed C t values for resolvin receptors ALX and ChemR23 mRNA in synovium ( A ) and media |
| image_url | https://www.ebi.ac.uk/europepmc/articles/PMC5763389/bin/ART-69-996-g001.jpg |
| paper_title | Targeting the D Series Resolvin Receptor System for the Treatment of Osteoarthritis Pain. |
| figure_label | Figure 1 |
| figure_number | 1 |
| _schema_version | 1 |
| source_strategy | pmc_api |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.